Yu-Kai Tang

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 12, 2023
Cost-effectiveness analysis of sintilimab plus IBI305 versus sorafenib for unresectable hepatic cell carcinoma in China.

Zhe Xu, Zhuo-Miao Ye, Yu-Kai Tang

Pageof 1

Frequent Collaborators

1 joint publications

Zhuo-Miao Ye

1 joint publications

Qin Zhou

1 joint publications

Xiang-Ping Li